Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...

European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...

An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...

An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...

VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation at Retina World ...

Nationwide survey finds nearly half of people with inherited retinal disease waited more than five years for genetic ...

Artificial intelligence (AI) has drawn interest in ophthalmology for its potential to track disease trends in huge populations, such as the 38.4 million people in the United States with diabetes who ...

Please provide your email address to receive an email when new articles are posted on . Patients with inherited retinal diseases may present with seemingly routine conditions. Look for comorbid ...

AI Retinal Imaging and Alzheimer’s Detection. AI retinal imaging could help identify adults needing Alzheimer’s disease referral in primary care settings. AI retinal imaging i ...

RESEARCH TRIANGLE PARK, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...

New research challenges concerns that tirzepatide harms the eyes, finding lower rates of diabetic retinopathy instead.